ction or formulation process and, to produce thecombined preparation, is packaged in a container, such as a capsule, a sachet or a drinking straw for administration to patients in the same manner as the separately formulated dosage forms containing clavulanic acid.In the combination pharmaceutical preparation according to the invention, the ratio by weight of the clavulanic acid-containing dosage